Log in
Enquire now
Emerald Therapeutics

Emerald Therapeutics

Emerald Therapeutics is a biotechnology company located in San Fransisco, California, founded by Brian Frezza and DJ Klienbaum in 2010. Emerald Therapeutics offers cloud a based software and hardware platform that allows researchers to remotely perform automated scientific laboratory experiments.

OverviewStructured DataIssuesContributors

Contents

emeraldcloudlab.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Synthetic biology
Synthetic biology
Biotechnology
Biotechnology
Biology
Biology
Technology
Technology
Therapeutics
Therapeutics
Software
Software
Cloud computing
Cloud computing
0
...
Location
South San Francisco, California
South San Francisco, California
United States
United States
California
California
San Francisco
San Francisco
B2X
B2B
B2B
Founder
DJ Kleinbaum
DJ Kleinbaum
AngelList URL
angel.co/emerald-therapeutics
Date Incorporated
2010
Full Address
844 Dubuque Ave South San Francisco, CA 94080
Investors
Founders Fund
Founders Fund
‌
James Hong (entrepreneur)
Max Levchin
Max Levchin
Ruchi Sanghvi
Ruchi Sanghvi
Incite.org
Incite.org
Ashby Monk
Ashby Monk
Founded Date
2010
Total Funding Amount (USD)
22,800,000
Latest Funding Type
Series A
Series A
Wellfound ID
emerald-therapeutics

Other attributes

Company Operating Status
Active

Emerald Therapeutics is a biotechnology company located in the San Francisco Bay Area, California, and was founded in 2013 by Brian Frezza and DJ Kleinbaum. The company offers a cloud based software and hardware integration platform, called the Emerald Cloud Lab (ECL), allowing researchers to perform experiments remotely in an automated lab.

The Emerald Cloud Lab provides researchers control over how experiments are carried out in the lab, and gives them the ability to adjust future lab protocols based on data generated from samples, laboratory instruments, and environmental control systems. The Emerald Cloud Lab also comes equipped with built-in tools for data analysis, manipulation, visualization, and modelling. Emerald Therapeutics claims their Emerald Cloud Lab allows scientists to achieve lower overhead costs and greater reproducibility compared to traditional laboratory experimental setups.

Funding
Series A

On December 27, 2010 Emerald Therapeutics announced their series A funding round and closed with $7,500,000 in funding from James Hong.

Series B

On March 1, 2014 Emerald Therapeutics announced their series B funding round and closed the round with $6,000,000 in funding from Schooner Capital, Founders Fund, and Max Levchin.

Series C

On June 19, 2015 Emerald Therapeutics announced raising $20,500,000 in funding during their series C funding round from Western Technology Investment, Sound Ventures, Schooner Capital, OS Fund, and Founders Fund.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Founders Fund Backs a Robotic Lab that Puts Science in the Cloud

James Temple

https://www.recode.net/2014/6/30/11628450/founders-fund-backs-a-robotic-lab-that-puts-science-in-the-cloud

News Article

References

Find more companies like Emerald Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.